Role of urinary biomarkers in the diagnosis of congenital upper urinary tract obstruction

Indian Journal of Urology

Volumn 24, Issue 3, 2008, Pages 313-319

  Shokeir, Ahmed A ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Children; Kidney; Obstruction; Urine

Indexed keywords

EID: 50949087721     PISSN: 09701591     EISSN: 19983824     Source Type: Journal    
DOI: 10.4103/0970-1591.42611     Document Type: Review

References (57)

1. Chevalier RL. Perinatal obstructive nephropathy. Semi Perinat 2004;28:124-31.
2. Disandro MJ, Kogan BA. Neonatal management: Role for early intervention. Urol Clin North Am 1998;25:187-97.
3. Koff SA. Neonatal management of unilateral hydronephrosis: Role for delayed intervention. Urol Clin North Am 1998;25:181-6.
4. Basile DP. The transforming growth factor β system in kidney disease and repair: Recent progress and future directions. Curr Opin Nephrol Hypertens 1999;8:21-30.
5. 1, in renal parenchymal scarring following childhood urinary tract infection. Kidney Int 2002;61:61-7.
6. 1 polymorphisms with chronic renal disease. J Nephrol 2004;17:794-9.
7. 1. Am J Nephrol 2006;26: 186-93.
8. Ishidoya S, Morrissey J, McCracken R, Klahr S. Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy. Kidney Int 1996;49:1110-9.
9. 1 and its receptors related to the ureteric fibrosis in a rat model of obstructive uropathy. J Urol 2000;163:1298-303.
10. Honkanen E, Teppo AM, Tornroth T, Groop PH, Gronhagen-Riska C. Urinar y transforming growth factor-βl in membranous glomerulonephritis. Nephrol Dial Transplant 1997;12:2562-8.
11. Walton G, Buttyan R, Garcia-Montes E, Olsson CA, Hensle T W, Swaczuk IS. Renal growth factor expression during the early phase of experimental hydronephrosis. J Urol 1992;148:510-4.
12. Medjebeur AA, Bussieres L, Gasser B, Gimonet V, Laborde K. Experimental bilateral urinary obstruction in fetal sheep: Transforming growth factor-beta I expression. Am J Physiol 1997;273:F372-9.
13. Seseke F, Thelen P, Hemmerlein B, Kliese D, Zoller G, Ringert RH. Histologic and molecular evidence of obstructive uropathy in rats with hereditary congenital hydronephrosis. Urol Res 2000;28:104-9.
14. Palmer LS, Maizels M, Kaplan WE, Firlit CF, Cheng EY. Urine levels of transforming growth factor-beta-l in children with ureteropelvic junction obstruction. Urology 1997;50:769-73.
15. 1 concentration in the diagnosis of upper urinary tract obstruction in children. J Urol 2002;168:1798-800.
16. 1 and epidermal growth factor BJU Int 2007;99:899-903.
17. 1 in IgA nephropathy. Am J Kidney Dis 2001;38:1191-8.
18. 1 in various types of nephropathy. Pharmacol Res 2004;49:293-8.
19. Cha DR, Kim IS, Kang YS, et al. Urinary concentration of transforming growth factor-β-inducible gene-h3 (βig-h3) in patients with type 2 diabetes mellitus. Diabet Med 2005;22:14-20.
20. Boonstra J. Growth factor-induced signal transduction in adherent mammalian cells is sensitive to gravity. FASEB J 1999;13:S35-42.
21. Breyer JA, Cohen S. The epidermal growth factor precursor isolated from murine kidney membranes (chemical characterization and biological properties). J Biol Chem 1990;265:16564-70.
22. Harris RC. Potential physiologic roles for epidermal growth factor in the kidney. Am J Kidney Dis 1991;17:627-30.
23. Chung KH, Chevalier RL. Arrested development of the neonatal kidney following chronic ureteral obstruction. J Urol 1996;155:1139-44.
24. Lin SY, Makino K, Xia W, Matin A, Wen Y, Kwong K Y, et al. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nature Cell Biol 2001;3:802-8.
25. Kiley SC, Thornhill BA, Belyea BC, Neale K, Forbes MS, Luetteke NC, et al. Epidermal growth factor potentiates renal cell death in hydronephrotic neonatal mice, but cell survival in rats. Kidney Int 2005;68:504-14.
26. Bartoli F, Gesualdo L, Paradies G, Galdarulo E, Infante B, Grandaliano G, et al. Renal expression of monocyte chemotactic protein and epidermal growth factor in children with obstructive hydronephrosis. J Pediatr Surg 2000;35:569-72.
27. 1 in the stenotic tissue of congenital pelviureteric junction obstruction in children. J Pediat Surg 2003;38:1656-60.
28. Grandaliano G, Gesualde L, Bartoli F, Ranieri E, Monno R, Leggio A, et al. MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy. Kidney Int 2000;58:182-92.
29. Moridaira K, Morrissey J, Fitzgerald M, Gvo G, McCracken R, Tolley T, et al. ACE inhibition increases expression of the ETB receptor in kidneys of mice with unilateral obstruction. Am J Physiol 2003;284:F209-17.
30. Josephson S, Hemsen A. Renal tissue endothelin in long term complete ureteric obstruction in the young rat. Urol Int 1994;53:57-61.
31. Kelleher JP, Shah V, Godley ML, Wakefield AJ, Gordon I, Ransley PG, et al. Urinary endothelin 1 (ET1) in complete ureteric obstruction in the miniature pig. Urol Res 1992;20:63-5.
32. Feldman DL, Mogelsky TC, Chou M, Jeng AY. Enhanced expression of renal endothelin-converting enzyme-l and endothelin-A-receptor mRNA in rats with interstitial fibrosis following ureter ligation. J Cardiovasc Pharmacol 2000;36:S255-9.
33. Kahn SA, Gulmi FA, Chou SY, Mooppan VM, Kim H. Contribution of endothelin-1 to renal vasoconstriction in unilateral ureteral obstruction: Reversal by verapamil. J Urol 1997;157:1957-62.
34. Reyes AA, Klahr S. Renal function after release of ureteral obstruction: Role of endothelin and the renal artery endothelium. Kidney Int 1992;42:632-8.
35. Hegarty NJ, Young LS, O'Neill AJ, William R, Watson G, Fitzpatrick JM. Endothelin in unilateral ureteral obstruction: Vascular and cellular effects. J Urol 2003;169:740-4.
36. Miller J, Hesse M, Diemer T, Haenze J, Knerr I, Rascher W, et al. Congenital unilateral ureteropelvic junction obstruction of the rat: A useful animal model for human ureteropelvic junction obstruction. Urology 2004;63:190-4.
37. Knerr I, Nyul Z, Miller J, Rosch W, Dotsch J, Repp R, et al. Increased endothelin-l and decreased adrenomodullin gene expression in the stenotic tissue of congenital pelviureteric junction obstruction in children. Br J UroI 2001;87:667-71.
38. Taha MA, Shokeir AA, Osman HG, Abd El-Aziz A F, Farahat SE. Diagnosis of ureteropelvic junction obstruction in children:Role of endothelin-1 in voided urine. Urology 2007;69:560-5.
39. Everaert K, Kerckhaert W, Delanghe J, Lameire N, Sturley W, Van de Wiele C, et al. Elevated tubular proteinuria, albuminuria and decreased urinary N-acetyl-β-D-glucosaminidase activity following unilateral total ureteral obstruction in rats. Urol Res 1998;26:285-9.
40. Price RG. Measurement of N- acetyl-β-Glucosaminidose and its iso-enzymes in urine: Methods and clinical application. Eur J Clin Chem 1992;30:693-705.
41. Ring E, Eber E, Erwa W, Zach MS. Urinary N-acetyl-β-D- Glucosarninidase activity in patients with cystic fibrosis on long term gentamicin inhalation. Arch Dis Child 1998;78:540-3.
42. Tataranni G, Farinellelli R, Zavagli G, Logallo G, Farinelli A. Tubule recovery after obstructive nephropathy relief: The value of enzymuria and microproteinuria. J Urol 1987;138:24-7.
43. Huland H, Gonnermann D, Werner B, Possin U. A new test to predict reversibility of hydronephrotic atrophy after stable partial unilateral ureteral obstruction. J Urol 1988;140:1591-4.
44. De Gennaro M, Silveri M, Capitanucci ML, Silvano A, Colistro F, Villani A, et al. N-acetyl-glucosaminidase (NAG) excretion in partially obstructed wealing rats. Int Urol Nephrol 2000;32:215-8.
45. Carr MC, Peters CA, Retik AB, Mandell J. Urinary levels of the renal tubular enzyme N-acetyl-β-D-Glucosaminidase in unilateral obstructive uropathy. J Urol 1994;151:442-5.
46. Taha MA, Shokeir AA, Osman HG, Abd El-Aziz AF, Farahat SE. Obstructed versus dilated nonobstructed kidneys in children with congenital ureteropelvic junction narrowing: Role of urinary tubular enzymes. J Urol 2007;178:640-6.
47. Schaeffer AJ. Infection of the urinary tract. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ, editors. Campbell's urology. USA: Saunders Co; 2002. p. 515-602.
48. Jung K, Kirschner P, Wille A, Brien G. Excretion of urinary enzymes after extracorporeal shock wave lithotripsy: A critical reevaluation. J Urol 1993;149:1409-13.
49. Mysliwiec M, Zorena K, Balcerska A, Mysliwska J, Lipowski P, Raczynska K. The activity of N-acety1-beta-D-glucosaminidase and tumor necrosis factor-alpha at early stage of diabetic retinopathy development in type 1 diabetes mellitus children. Clin Biochem 2006;39:851.
50. Rennke HG, Olsen JL, Venkatachalam MA. Glomerular filtration of macromolecules: Normal mechanisms and the pathogenesis of proteinuria. Contrib Nephrol 1981;24:30-41.
51. Johnson AM, Rohlfs EM, Silverman LM. Proteins. In: Burtis CA, Ashwood ER, editors. Tietz Textbook of Clinical Chemistry. USA: Saunders Company; 1999. p. 477-540.
52. Newman DJ, Price CP. Renal function and nitrogen metabolites. In: Burtis CA, Ashwood ER, editors. Tietz Textbook of Clinical Chemistry. USA: Saunders Company; 1999. p. 1204-70.
53. Everaert K, Van de Wiele C, Delanghe J, Eecken HV, Van Haelst IP, Van de Voorde I, et al. Urinary excretion of tubular proteins and the technetium-99m dimercapto succinic acid (DMSA) absolute renal uptake in partial ureteral obstruction in rats: A functional evaluation of hydronephrotic kidneys. Urol Res 1999;27:127-33.
54. Lama G, Ferraraccio F, laccarino F, Luongo I, Marte A, Rambaldi P F, et al. Pelviureteral junction obstruction: Correlation of renal cell apoptosis and differential renal function. J Urol 2003;169:2335-8.
55. Shokeir AA. The diagnosis of upper urinary tract obstruction. Br J Urol 1999;83:893-901.
56. Guder WG, Ross BD. Enzyme distribution along the nephron. Kidney Int 1984;26:101-11.
57. Price RG. Early markers of nephrotoxicity. Comp Clin Pathol 2002;11:2-7.